9 -{[2 -Hydroxy-I -(hydroxymethyl)ethoxy]methyllguanine (2'-nor-2'-deoxyguanosine; 2'NDG) selectively inhibits the replication of herpes group viruses. In cell culture studies 2'NDG was at least 10-fold more potent than acyclovir (ACV) in inhibition of human cytomegalovirus replication and Epstein-Barr virus-induced lymphocyte transformation and was about as effective as ACV in inhibition of herpes simplex viruses 1 and 2 and varicella zoster virus. Orally administered 2'NDG was 6-to 50-fold more efficacious than ACV in treating systemic or local HSV-1 infection or HSV-2 intravaginal infection in mice. The mode of action of 2'NDG appears to involve phosphorylation by herpes simplex virus thymidine kinase and subsequent phosphorylations by cellular kinases to produce 2'NDG triphosphate, which is a potent inhibitor of herpes virus DNA polymerase. Compared to ACV, 2'NDG was a more efficient substrate for HSV-1 thymidine kinase (Vma./Km for 2'NDG 30-fold higher than that for ACV), whereas 2'NDG monophosphate is a more efficient substrate for GMP kinase (Vm./Km for 2'NDG monophosphate 492-fold higher than that for ACV monophosphate). The combined effect is more rapid production of the inhibitory triphosphate from 2'NDG than from ACV.As part of our studies on the structure-activity relationships of herpes virus encoded thymidine kinase (TK) and DNA polymerase, a nucleoside analog, 9-{[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl}guanine (2'-nor-2'-deoxyguanosine; 2'NDG) (1-3) was synthesized. 2'NDG is an efficient substrate for the herpes simplex virus 1 (HSV-1) TK and is readily converted to the triphosphate, a potent inhibitor of viral DNA polymerase (1).In the present studies, a chemical synthesis of 2'NDG, the characteristics of its selective phosphorylation by HSV-1 TK, and its rapid conversion to the triphosphate are more fully described. In addition, data are presented demonstrating that the rapid phosphorylation of 2'NDG is correlated with potent inhibition of herpes virus replication in cell cultures and both prophylactic and therapeutic efficacy against herpes virus infections in mice.MATERIALS AND METHODS Materials. Phosphocreatine, creatine kinase, ATP, deoxythymidine, and dGMP were purchased from Sigma; GMP kinase (hog brain) and NADH, from Boehringer Mannheim; lactate dehydrogenase, from Worthington; [methyl-3H] by determining the drug concentration (,ug/ml) required to confer a 50% plaque inhibition on duplicate cell monolayers [for HSV-1, VZV, HCMV, Mengo virus, and vaccinia virus]. For both assays, the antiviral compound was added to the maintenance medium at the time of infection. Viral cytopathic effect was evaluated after incubation for 5 days at 37°C, and plaque development was evaluated after incubation for 3 days (7 days for HCMV) at 370C. Inhibition of EBV replication was measured by prevention of transformation of normal cord lymphocytes to lymphoblastoid cells. In brief, lymphocyte-rich suspensions were prepared from fresh, heparinized human cord blood specimens by differential centrifu...